✦ LIBER ✦

P-344 Celecoxib combined with weekly irinotecan (CPT-11) and docetaxel for the treatment of patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Argiris, Athanassios

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan (CPT-11) in combination with

✍ Kunihiko Kobayashi; Ayako Shinbara; Mitsuhiro Kamimura; Yuichiro Takeda; Koichir 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 405 KB

Activity of weekly irinotecan (CPT-11) i

✍ Rosa Sánchez; Emilio Esteban; Isabel Palacio; Yolanda Fernández; Isabel Muñiz; J 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 59 KB

144 Phase III study of docetaxel and iri

✍ Kudoh, S.; Negoro, S.; Masuda, N.; Sugiura, T.; Shimokata, H.; Fukuoka, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 146 KB

246 Phase I–II study of weekly irinoteca

✍ Nitta, T.; Negoro, S.; Takeda, K.; Kudoh, S.; Masuda, N.; Takada, M.; Fukuoka, M 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Cisplatin and irinotecan (CPT-11) as sec

✍ Kakolyris, S; Kouroussis, Ch; Souglakos, J; Agelaki, S; Kalbakis, K; Vardakis, N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Second line treatment of antiangiogenic

✍ Stani, Simonetta Chiara; Sarmiento, Roberta; Mansueto, Giovanni; Bonginelli, Pao 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB